Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.
Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, Konstan MW, Moss R, Retsch-Bogart G, Wagener J, Waltz D, Wilmott R, Zeitlin PL, Ramsey B; Cystic Fibrosis Therapeutics Development Network Study Group.
Gibson RL, et al. Among authors: emerson j.
Am J Respir Crit Care Med. 2003 Mar 15;167(6):841-9. doi: 10.1164/rccm.200208-855OC. Epub 2002 Dec 12.
Am J Respir Crit Care Med. 2003.
PMID: 12480612
Clinical Trial.